Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline and Indomethacin for Resistant PDA
NCT00616382Phase 2Unknown
- Sponsor
- Shaare Zedek Medical Center
- Start
- Mar 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentoxifylline in patent ductus arteriosus (PDA), sponsored by Shaare Zedek Medical Center. Status: unknown.
02
Drugs
pentoxifylline
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NCT00616382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616382.